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The current use of feasibility studies in the
assessment of feasibility for stepped-wedge
cluster randomised trials: a systematic
review
Caroline A. Kristunas1* , Karla Hemming2, Helen Eborall1, Sandra Eldridge3 and Laura J. Gray1
Abstract
Background: Stepped-wedge cluster randomised trials (SW-CRTs) are a pragmatic trial design, providing an
unprecedented opportunity to increase the robustness of evidence underpinning implementation and quality
improvement interventions. Given the complexity of the SW-CRT, the likelihood of trials not delivering on their
objectives will be mitigated if a feasibility study precedes the definitive trial. It is not currently known if feasibility
studies are being conducted for SW-CRTs nor what the objectives of these studies are.
Methods: Searches were conducted of several databases to identify published feasibility studies which were designed
to inform a future SW-CRT. For each eligible study, data were extracted on the characteristics of and rationale for the
feasibility study; the process for determining progression to the main trial; how the feasibility study informed the main
trial; and whether the main trial went ahead. A narrative synthesis and descriptive analysis are presented.
Results: Eleven feasibility studies were identified, which included eight completed study reports and three protocols.
Three studies used a stepped-wedge design and these were the only studies to be randomised. Studies were
predominantly of a mixed-methods design. Only one study assessed specific features related to the feasibility of using
a SW-CRT and one investigated the time taken to complete the study procedures. The other studies were mostly
assessing the feasibility and acceptability of the intervention.
Conclusion: Published feasibility studies for SW-CRTs are scarce and those that are being reported do not investigate
issues specific to the complexities of the trial design. When conducting feasibility studies in advance of a definitive SW-
CRT, researchers should consider assessing the feasibility of study procedures, particularly those specific to the SW-CRT
design, and ensure that the findings are published for the benefit of other researchers.
Keywords: Stepped-wedge trial, Cluster randomised trial, Pilot trial, Feasibility study, Systematic review
Background
The stepped-wedge cluster randomised trial (SW-CRT)
is a novel and appealing trial design which can be used
for the evaluation of interventions during routine imple-
mentation [1, 2]. The design involves randomisation of
clusters to sequences which dictate the order at which
the clusters cross from the control to the intervention
condition [3]. In general, this involves all clusters start-
ing the trial in the control condition, followed by a
staggered introduction of the clusters to the interven-
tion, resulting in all clusters receiving the intervention
by the end of the trial [3]. The implementation of inter-
ventions under evaluation can often proceed in much
the same way as it would have had the evaluation not
been taking place, with the exception of the order of im-
plementation [3]. This means the design has the poten-
tial to provide real world evidence of effectiveness; that
can be generalised; and can be implemented with min-
imal disruption. With the increasing availability of rou-
tinely collected data, the trial design has the potential to* Correspondence: cak21@le.ac.uk
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become the gold standard for the evaluation of imple-
mentation and quality improvement interventions.
The use of the SW-CRT is seeing an unprecedented
and exponential increase [4]. However, some of the com-
plexities of the trial design can put studies at risk of not
delivering on their objectives [5, 6]. In particular, due to
the staggered implementation of the intervention, there
is the potential for the scheduled timings of the trial to
be disrupted. Disruptions to the planned implementation
schedule and organisation of the trial may have reper-
cussions that ultimately result in the trial being unsuc-
cessful. In addition, it is generally required for all
clusters to be recruited prior to any randomisation tak-
ing place. If recruitment of clusters is slower than ex-
pected then this can severely delay the start of the trial
or could result in fewer clusters being recruited and an
underpowered trial. Getting the timings of the trial right,
particularly the timing of the clusters starting the inter-
vention can be a challenge. Without first testing the im-
plementation of the intervention, it may be difficult to
determine how long the intervention will take to embed
in a cluster, and therefore how long the periods need to
be between clusters starting the intervention. Maintain-
ing consistency in participant recruitment over the dur-
ation of the trial may be difficult, especially when the
cluster changes from control to intervention condition.
When continuously recruiting throughout the trial varia-
tions in the number or type of participants can occur.
These variations can relate to variations in the level of
engagement from those recruiting participants, which
may wane as the trial progresses, or as a result of staff
turnover. These challenges surrounding the design and
conduct of SW-CRTs mean feasibility studies could be
particularly useful.
Feasibility and pilot studies are small scale studies con-
ducted prior to a definitive trial. They aim to guide the
planning or design of the trial, or determine whether the
main trial is feasible and if not, what issues, if any, can
be resolved to make the main trial feasible [7–10]. Feasi-
bility studies can be designed to investigate a vast range
of issues [11]. Some may be focussed on testing the
feasibility of the intervention; for example whether the
intervention is acceptable to its intended recipients;
whether it is suitable for the environment where it will
be introduced; and whether there are any challenges that
might arise during the implementation [11, 12]. Other
feasibility studies may be more concerned with assessing
the feasibility of the trial processes: for example testing
the methods of data collection; the acceptability of the
randomisation or recruitment procedures; or testing if
there are sufficient resources available to conduct the
trial [12]. Depending on its objectives a feasibility study
may or may not have the same design as the main trial.
Pilot studies can be defined as a subset of feasibility
studies, where pilot studies have a particular design fea-
ture [10, 13]. A pilot study is conducted as a small scale
version of all or part of the future definitive RCT (that
may or may not be randomised) [10, 13]. Throughout,
the term feasibility study will be used to encompass both
feasibility and pilot studies.
Testing and refining the trial processes for SW-CRTs
will be pivotal to their success. For example, it may tran-
spire that due to resource availability or the complexity
of the intervention, a limited number of clusters can
simultaneously cross from the control to the interven-
tion. The resource levels needed to start and maintain a
cluster in the intervention condition can be investigated
in a feasibility study. The length of time required be-
tween clusters crossing to the intervention might also be
important; and again can be investigated in a feasibility
study. This time should be long enough to allow the
intervention to become embedded in a cluster before a
measure of the outcome is obtained, whilst being short
enough to allow the trial to complete within a set fund-
ing period. It might also be important to determine if re-
cruitment of participants can be done in such as way so
as not to be influenced by any knowledge of the inter-
vention condition (which can induce biases) [14].
Up until now, it has not been known whether feasibil-
ity studies are being used to inform the design of
SW-CRTs and if they are, which issues are being investi-
gated. A recent systematic review of SW-CRTs [4] iden-
tified three pilot studies for SW-CRTs, which were
themselves of a stepped-wedge design. However, since
not all published feasibility studies for SW-CRTs will
have a stepped-wedge design, not all will have been
identified by previous reviews. This review aims to gain
an insight into how feasibility studies are being used to
inform the design of SW-CRTs. Specifically, our objec-
tives were to:
 Systematically identify published feasibility studies
designed to inform SW-CRTs;
 Ascertain the design characteristics of and rationale
for these feasibility studies;
 Establish how the feasibility studies informed the
main trials.
Methods
Search strategy
Feasibility studies for SW-CRTs, published in English,
were identified via electronic searches conducted on 6th
February 2017 of the online published databases Ovid
MEDLINE (from 1946), Scopus (from 1966), Embase
(from 1947) and PsycINFO (from 1967). An example of
the search strategy used is outlined in Table 1 [15] and
was based on previously published search strategies [1,
7, 12, 16, 17].
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Inclusion criteria
Eligible studies were full reports or protocols of feasibil-
ity studies conducted to inform a future SW-CRT. For
the purpose of this review, a feasibility study for a
SW-CRT was defined as any study which aimed to as-
certain the feasibility of a planned SW-CRT, through the
assessment of issues other than solely the refinement of
the intervention. We consider pilot studies to be a sub-
set of feasibility studies and were therefore eligible for
inclusion in this review.
No restrictions were placed on the design of the feasibil-
ity study, so it was not necessary for the feasibility study
to be of a stepped-wedge design, or even randomised. The
feasibility study should, however, have focussed objectives
to ascertain the feasibility of a planned SW-CRT and make
it clear how the findings of the study will inform the main
trial, which must be intended to be of an SW-CRT design.
An SW-CRT is defined as any trial that randomises clus-
ters to two or more steps (time-points at which clusters
have a unidirectional change of treatment condition).
Studies for which the intended definitive trial is individu-
ally randomised, has a bidirectional cross-over design or is
non-randomised have been excluded.
Screening
Two reviewers (CK & Maria Yao) independently and in a
random order screened the titles and abstracts of the
identified studies for eligibility. For those studies not ex-
cluded at the initial screening, full-text articles were ob-
tained and the same duplicate method of assessment
used. Ineligible studies were excluded and the reason for
exclusion noted. If any additional information was re-
quired the authors were contacted and attempts were
made to access any protocols for the identified feasibility
studies. For each eligible study, the reference lists were
also checked for any potentially eligible studies.
Data extraction
Data extraction for eligible studies was done independ-
ently and in duplicate in a random order by two re-
viewers (CK & (KH or LG)), using a data extraction
form that had been tested, revised and finalised using a
small number of the studies. Extracted data was man-
aged in Microsoft Excel V.2013.
Information about the design of each feasibility study was
extracted. This included how the authors defined their
study (as a pilot, feasibility study or something else); the size
of the study and how the sample size was justified; and
whether the study has been registered with a recognised
clinical trial registry, such as ClinicalTrials.gov. In addition,
information was extracted on blinding, randomisation and
overall design of the feasibility study (parallel,
stepped-wedge etc.). The rationales for conducting each
feasibility study prior to a main trial were obtained by
extracting the specific aims of each study. These were cate-
gorised into process (feasibility of the processes that take
place during the trial), resource (time, people and budget is-
sues), management (feasibility of collaborations and coord-
ination of teams) and scientific type (assess scientific
processes and estimation of parameters) motivations (more
detail is included in the published protocol [15]).
Information on the types of analysis conducted and the
emphasis put on any results were extracted. Information
was also extracted on any hard or soft stopping rules that
were in place and the criteria used to determine whether
the main trial would be feasible or not. Whether the deci-
sion was made to go ahead with the main trial and how the
feasibility study informed or resulted in changes being
made to the main trial were recorded, along with any infor-
mation on whether any of the participants from the feasibil-
ity study would also be taking part in the main trial.
Analysis of results
We present a narrative synthesis of our findings, as well as
a descriptive analysis of the study characteristics of each
eligible feasibility study included in the review. We also
present a critical appraisal of a single case study which
highlights specific issues regarding feasibility studies and
SW-CRTs [Additional File 1]. Where appropriate, this re-
port adheres to the Preferred Reporting Items for System-
atic reviews and Meta-Analyses (PRISMA) statement [18].
Results
A total of 1861 records were identified from the search
of the databases, of which 11 studies were found to be
eligible and are included in this analysis [Fig. 1;
Additional File 2].
Table 1 Example search strategy for Ovid MEDLINE
1. “pilot*”.mp
2. “feasibil*”.mp
3. 1 OR 2
4. “step* wedge*”.mp
5. “step*wedge*”.mp
6. “delay* intervention”.mp
7. “experimental* staged introduction”.mp
8. (“one* direction* crossover design” OR “one* direction* cross*
over design”).mp
9. (“incremental* recruitment” OR “incremental* introduction” OR
“incremental* implementation” OR “incremental* allocation”).mp
10. (“phased* recruitment” OR “phased* introduction” OR “phased*
implementation” OR “phased* allocation”).mp
11. (“staggered* recruitment” OR “staggered* introduction” OR
“staggered* implementation” OR “staggered*allocation”).mp
12. (“stepwise* recruitment” OR “stepwise* introduction” OR
“stepwise* implementation” OR “stepwise*allocation”).mp
13. (“step*wise* recruitment” OR “step*wise* introduction” OR
“step*wise* implementation” OR “step*wise*allocation”).mp
14. (“delayed* recruitment” OR “delayed* introduction” OR
“delayed* implementation” OR “delayed*allocation”).mp
15. or/4–14
16. 3 AND 15
17. limit 16 to English language
* truncation symbol, for example "pilot*" retrieves "pilots" as well as "pilot"
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Of these 11 studies included, less than half reported that
the study had been registered (Table 2) [Additional File 3].
The majority of the identified studies were reports of re-
sults, but three protocols were also identified. Just over half
of the studies described themselves as a pilot study, with
the others using terms such as “feasibility study”, “accept-
ability and feasibility pilot”, “consultation exercise” or “for-
mative research”.
Three of the identified studies were of a stepped-wedge de-
sign, with two of these having a qualitative component. Over
half of the identified studies used mixed methods; and most
(73%) were external to the intended main trial. The duration
of the studies ranged from 16weeks to two years, with a me-
dian duration of one year (interquartile range (IQR)
(months): 4.7, 15). Three of the studies were randomised (all
at the cluster level and all having a stepped-wedge design)
with no restrictions to the randomisation mentioned. Blind-
ing was present in one of these [19].
The majority of the included studies were conducted
in health care settings, where the clusters were mostly
defined as hospitals, clinics, or wards. The median num-
ber of clusters in each study was 3.5 (IQR: 1.8, 6). The
study participants were mostly patients, healthcare pro-
fessionals or both, including on average 109 (IQR: 35,
2180) participants. The majority of studies used a con-
venience sample and for three studies the rationale for
the sample size was unclear.
Rationales for conducting the feasibility study
The studies reported a range of rationales, including
process and resource rationales, though none reported
any management rationales [Table 3, Additional File 4].
The most common process type motivations were in-
vestigating acceptability of the intervention (64%);
identifying issues or barriers to implementation (55%)
and intervention adherence (36%). Six studies investi-
gated outcome measure related process type motiva-
tions; either choice of outcome measure; testing of data
collection methods; or assessing the amount of missing
data. Only one study assessed the feasibility of the pro-
cesses specifically relating to the use of the
stepped-wedge design. A description of this study is
given in [Additional File 1].
Only three of the identified studies stated any resource
type motivations for conducting the study. Each of the
following were assessed by one of the studies: the re-
sources used in the intervention; the post-intervention
impacts on service use and staff time; the time taken to
complete study procedures; waiting and consultation
times; and patient volumes and staffing levels. None of
the feasibility studies identified listed any management
type issues that they investigated.
Some scientific type motivations were investigated, the
most common being an estimation of the potential ef-
fectiveness of the intervention (45%). In addition, some
studies aimed to assess the cost-effectiveness/theoretical
cost savings of introducing the intervention or intended
to use information gained from the feasibility study to
inform the sample size calculation.
Progression to a main trial
Only two (18%) studies gave any criteria for determining
the success of the feasibility study and deciding whether
to proceed to a main trial. One study provided specific
criteria, stating the threshold enrolment rate required
and the lowest proportion of visits that needed to be
completed and sessions that needed to be attended [20].
The criteria for the other study were not as specific: the
Fig. 1 Flow diagram: The flow of information through the different stages of the systematic review
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completion of the economic modelling of the pilot data
would “underpin the decision to progress to a main trial”
[21].
One study put in place a stopping rule. The decision
as to whether to continue the study was based on the
change seen in the outcome from a period prior to the
implementation of the intervention [21]. This study is
described in more detail in [Additional File 1]. None of
the feasibility studies that had been conducted at the
time of this review were stopped prior to completion.
Analysis method
The majority of the studies (55%) used a mixed-methods
approach to analysing their data. The quantitative
methods used included descriptive statistics, simple stat-
istical tests and generalised linear mixed models. The
Table 2 Characteristics of identified feasibility studies
Characteristic Number (%)a
Study registered 5 (45)
Report of findings 8 (73)
Protocol 3 (27)
Study described as:
Pilot 6 (55)
Other 4 (36)
Not described 1 (9)
External feasibility study 8 (73)
Internal feasibility study 2 (18)
Unclear 1 (9)
Type of research:
Quantitative 3 (27)
Qualitative 1 (9)
Mixed 6 (55)
Unclear 1 (9)
Quantitative design:
Single-arm 4 (36)
Stepped-wedge 3 (27)
Parallel 1 (9)
Observational 1 (9)
Randomised 3 (27)
Setting:
Health care 9 (82)
Community 2 (18)
Cluster type:
Hospitals 3 (27)
Wards 4 (36)
Clinics 2 (18)
Geographical areas 2 (18)
Study duration (months) (median (IQR)) 12 (4.7, 15)
Number of clusters (median (IQR)) 3.5 (1.8, 6)
Participant type:
Healthcare professionals 1 (9)
Patients 5 (45)
Both healthcare professionals and patients 4 (36)
Other 1 (9)
Number of participants (median (IQR)) 109 (35, 2220)
Rational for sample size:
Convenience sample 6 (55)
Calculation based on the main clinical outcome 2 (18)
Not stated 3 (27)
awith denominator the total number of studies (n = 11) unless otherwise
stated, IQR interquartile range
Table 3 Rationales given for conducting the identified
feasibility studies
Rationales given Number
Process type motivations (n = 11):
Acceptability of intervention 7
Identify issues/barriers to implementation 6
Adherence to intervention 4
Development of intervention 3
Retention rate estimation 3
Determining outcome measures 2
Test data collection methods 2
Assess amount of missing data 2
Othera 5
Resource type motivations (n = 3):
Resources used in intervention 1
Post-intervention impact on service use and staff time 1
Time taken to complete study procedures 1
Waiting and consultation times 1
Patient volumes and staffing levels during study 1
Management type motivations (n = 0):
None reported 11
Scientific type motivations (n = 8):
Potential effectiveness of intervention 5
Assess cost-effectiveness/theoretical cost saving 3
Inform sample size calculation 3
Assess intervention safety 2
Estimate Intra Cluster Correlation Coefficient (ICC) 1
Assess correlation between measures 1
Assess distributional properties of measures 1
aparticipant satisfaction; assess values-treatment concordance; acceptability
relevance and importance of trial; test sampling methodologies; test feasibility
of using stepped-wedge design
n = the number of studies that gave any motivation of this type
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qualitative methods used included constant comparative
analysis, framework analysis, thematic analysis and con-
tent analysis. Hypothesis testing alone was used by two
(18%) of the studies to gain estimates of the effectiveness
of the intervention. Content analysis was the method of
choice for the one study which only used qualitative
methods. Two studies (18%) did not specify the method
of analysis that was used.
Remaining feasibility concerns and modifications required
Some feasibility concerns remained for the completed
studies. One study observed differential recruitment suc-
cess due to possible response bias, yet still deemed the
main trial to be feasible without changes [22]. Two stud-
ies also concluded their studies were feasible without
changes, despite some remaining concerns.
Even for those studies that listed no remaining con-
cerns, changes were still intended to be made. These in-
cluded changes to: the intervention [23], study
procedures [23, 24] and data collection methods [24].
One study which identified several barriers, found issues
predominately relating to time and resource availability
[25]. The study was found to be feasible with several
modifications, including the introduction of an adher-
ence and retention package. One of the studies did not
specify whether the main trial would be going ahead as a
result of the feasibility study [26].
The majority of the studies did not specify whether
the participants (55%) or clusters (64%) from the feasi-
bility study would be taking part in the future trial. For
four of the studies (36%) the commitment to using a
SW-CRT design for the future definitive trial was not as
strong as for the other trials. For these trials the
stepped-wedge design was considered to be the most ap-
propriate design for a future trial or the feasibility study
itself was an SW-CRT. The only study to specifically as-
sess the feasibility of using the stepped-wedge trial de-
sign, was one of the feasibility studies that was itself of a
stepped-wedge design [21]. This feasibility study is de-
scribed in [Additional File 1] along with a critical ap-
praisal of its objectives.
Discussion
Through a systematic review of the published literature
we have identified 11 feasibility studies (eight reports,
three protocols) conducted to inform SW-CRTs. Given
the increasing frequency with which SW-CRTs are being
used, it would be expected that there would be a greater
number of feasibility studies published for these trials.
This would suggest that few feasibility studies are being
conducted in advance of running a definitive SW-CRT
or that conducted feasibility studies are not being pub-
lished. Furthermore, of the few SW-CRTs that have pub-
lished feasibility studies, few have assessed the feasibility
issues surrounding the use of the SW-CRT design itself.
Given the complexities of the trial design, especially
around the timings of the roll-out of the intervention
under evaluation, evaluations using this trial design will
be at risk of not delivering on their objectives.
The SW-CRT is an emerging, innovative and poten-
tially very useful yet complex study design [3, 5, 6]. It
has been shown to be particularly useful for the evalu-
ation of interventions that would have been rolled out
regardless of the trial taking place, as the implementa-
tion can often proceed in much the same way whilst
providing randomised evidence of effectiveness [3]. In
this way SW-CRTs are assisting in the move towards
more pragmatic trials to answer routine pragmatic
healthcare questions. There have been many reviews of
SW-CRTs [1, 4, 16, 17, 27–32]. However, most reviews
have focussed on statistical methodology (particularly
sample size) and quality of reporting and none have
looked at the use of feasibility studies for these trials.
When designing a SW-CRT, there will often be aspects
of the design that cannot be informed by previous trials,
systematic reviews, routine data etc. and this informa-
tion might only be gained through the use of a feasibility
study. Obtaining this additional information can improve
the feasibility of the designed trial.
We ascertained the design characteristics and rationale
of the identified studies, in order to see how feasibility
studies are currently being used to inform the design of
SW-CRTs. In addition, we ascertained the processes
employed by these studies for determining progression
to a main trial, in order to see how feasibility studies are
being used to inform SW-CRTs.
The studies varied considerably in both their size and
duration, with some studies being completed in 16 weeks
whilst others took two years and some studies requiring
16 participants whilst others included observations from
more than 26,000 individuals. Many of the sample sizes
lacked clear justification. Three studies did not provide
any rationale for the size of the study and so it is not
possible to determine whether the studies were large
enough to accomplish their objectives or whether they
might be excessively large. Under the CONSORT 2010
statement extension for randomised pilot and feasibility
trials [10] the rationale for the numbers included in the
study should be provided, especially for those studies
where estimation of parameters such as recruitment
rates is an objective. For many of the studies one of the
main aims was to estimate the potential effectiveness of
the intervention, which should not feature as an object-
ive of a feasibility study as it will not be sufficiently pow-
ered for this [12]. Therefore, the decision as to whether
to continue with the study or to progress to the defini-
tive trial should not be based on any estimate of poten-
tial effectiveness from the feasibility study.
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Only one of the feasibility studies aimed to assess the
feasibility of using the stepped-wedge design, despite three
of the studies being of a stepped-wedge design themselves.
One study investigated the time taken to complete the
study procedures, whereas the rest of the studies were
mostly assessing the feasibility and acceptability of the
intervention itself. With the complexity of the design of a
SW-CRT, it is surprising to see so few of the studies investi-
gating issues that are specific to the SW-CRT design. How-
ever, with the current dearth of papers describing the
practical challenges of conducting a trial of this design,
maybe this comes as less of a surprise. A small number of
stepped-wedge trials that have been published, have re-
ported the challenges faced [33]. Known challenges include
delays in the start of the trial, poor recruitment and limited
quantity and quality of data [27, 33, 34]. Many of which
could be investigated using a feasibility study. Less than half
of the identified studies were registered. The importance of
registering feasibility studies has been highlighted by the
CONSORT 2010 statement extension for randomised pilot
and feasibility trials [10] and we reiterate this point. By reg-
istering feasibility studies it can make them easier to iden-
tify. Once identified these studies can be used to help
inform the design of future SW-CRTs, by highlighting iden-
tified feasibility issues associated with this design.
Strengths and limitations
Our review used a pre-specified search strategy, inclu-
sion and exclusion criteria and duplicate data extraction
in order to minimise potential sources of bias. The
search strategy included many terms used for SW-CRTs,
based on those included in other reviews [1, 16, 17] in
an attempt to capture those studies using some of the
less common terms. Yet, despite our best efforts there is
still the potential for some selection bias as our search
will not have captured those studies using other terms
to describe the stepped-wedge design and non-English
language studies. In addition, the results of our search
will be limited to feasibility studies that specify that the
main trial will be a SW-CRT in the title or abstract. An-
other added complexity and potential limitation is that
feasibility studies often go unpublished [7, 12]. A recent
review of feasibility studies funded by the National Insti-
tute for Health Research’s (NIHR) Research for Patient
Benefit (RfPB) programme found almost half of the stud-
ies that they looked at had not published results [35].
We included studies self-defining as either pilot or feasi-
bility studies; but other studies may have used other
self-defining terminology to describe these studies - al-
though this is likely to improve with the publication of
the CONSORT 2010 statement extension for rando-
mised pilot and feasibility trials [10].
Further work is required to highlight to researchers all
of the potential feasibility issues associated with the
SW-CRT, how some issues become more serious when
using the stepped-wedge design and to promote the use
of feasibility studies to inform these trials. The work pre-
sented here is part of a larger programme funded by the
National Institute for Health Research (NIHR), which in-
tends to identify the feasibility issues encountered by
SW-CRTs and ultimately lead to the development of
guidance on how feasibility studies can be conducted for
SW-CRTs.
Conclusions
Published feasibility studies to inform SW-CRTs are
scarce and those that are being published do not aim to
investigate many of the issues specific to this design of
trial. SW-CRTs are complex and compared to other de-
signs they are relatively inflexible to change once the
trial has commenced. There is the potential for feasibil-
ity studies to be really informative in the designing of
SW-CRTs, improving their design and giving them a
greater chance of being completed successfully, on time
and with the required sample size. We highlight the im-
portance of conducting a feasibility study prior to any
SW-CRT and encourage the publication of the findings
in order to help other researchers planning on conduct-
ing a SW-CRT. We also encourage the published reports
of completed SW-CRTs to highlight the challenges faced
during the trial in order to help future trials to avoid en-
countering the same issues and provide them with the
opportunity to investigate solutions to these issues dur-
ing their own feasibility studies.
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